These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3132174)

  • 21. Hyperammonemia in carnitine-deficient adult JVS mice used by starvation.
    Li XX; Kobayashi K; Horiuchi M; Jalil A; Yoshida G; Saheki T
    Metab Brain Dis; 2002 Dec; 17(4):359-66. PubMed ID: 12602512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. beta-Hydroxybutyrate oxidation is reduced and hepatic balance of ketone bodies and free fatty acids is unaltered in carnitine-depleted, pivalate-treated rats.
    Bianchi PB; Davis AT
    J Nutr; 1996 Nov; 126(11):2867-72. PubMed ID: 8914959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance.
    Thurston JH; Carroll JE; Hauhart RE; Schiro JA
    Life Sci; 1985 Apr; 36(17):1643-51. PubMed ID: 3921791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of carnitine supplementation in valproate-induced hyperammonaemia.
    Böhles H; Sewell AC; Wenzel D
    Acta Paediatr; 1996 Apr; 85(4):446-9. PubMed ID: 8740302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperammonemia decreases body fat content in rat.
    Miñana MD; Felipo V; Wallace R; Grisolía S
    FEBS Lett; 1989 Jun; 249(2):261-3. PubMed ID: 2737286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered hepatic fatty acid metabolism in endotoxicosis: effect of L-carnitine on survival.
    Takeyama N; Takagi D; Matsuo N; Kitazawa Y; Tanaka T
    Am J Physiol; 1989 Jan; 256(1 Pt 1):E31-8. PubMed ID: 2521428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. L-carnitine replacement therapy in chronic valproate treatment.
    Melegh B; Kerner J; Acsádi G; Lakatos J; Sándor A
    Neuropediatrics; 1990 Feb; 21(1):40-3. PubMed ID: 2107456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes.
    Coudé FX; Grimber G; Pelet A; Benoit Y
    Biochem Biophys Res Commun; 1983 Sep; 115(2):730-6. PubMed ID: 6414476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of the adverse chronic effects of the unsaturated derivative of valproic acid--2-n-propyl-4-pentenoic acid--on ketogenesis and liver coenzyme A metabolism by a single injection of pantothenate, carnitine, and acetylcysteine in developing mice.
    Thurston JH; Hauhart RE
    Pediatr Res; 1993 Jan; 33(1):72-6. PubMed ID: 8433865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatty acid uptake and metabolism to ketone bodies and triacyglycerol in rat and human hepatocyte cultures is dependent on chain-length and degree of saturation. Effects of carnitine and glucagon.
    Emmison N; Agius L
    FEBS Lett; 1988 Aug; 236(1):83-8. PubMed ID: 3402619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mechanism for valproate-induced hyperammonemia.
    Coudé FX; Rabier D; Cathelineau L; Grimber G; Parvy P; Kamoun P
    Adv Exp Med Biol; 1982; 153():153-61. PubMed ID: 6819763
    [No Abstract]   [Full Text] [Related]  

  • 32. Valproate-induced hyperammonemia of renal origin. Effects of valproate on glutamine transport in rat kidney mitochondria.
    Rumbach L; Cremel G; Marescaux C; Warter JM; Waksman A
    Biochem Pharmacol; 1989 Nov; 38(22):3963-7. PubMed ID: 2512930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amelioration of adverse effects of valproic acid on ketogenesis and liver coenzyme A metabolism by cotreatment with pantothenate and carnitine in developing mice: possible clinical significance.
    Thurston JH; Hauhart RE
    Pediatr Res; 1992 Apr; 31(4 Pt 1):419-23. PubMed ID: 1570210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatotoxicity in rat following administration of valproic acid.
    Sugimoto T; Woo M; Nishida N; Takeuchi T; Sakane Y; Kobayashi Y
    Epilepsia; 1987; 28(2):142-6. PubMed ID: 3102219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium valproate-induced hyperammonemia in the rat: role of the kidney.
    Warter JM; Imler M; Marescaux C; Chabrier G; Rumbach L; Micheletti G; Krieger J
    Eur J Pharmacol; 1983 Feb; 87(2-3):177-82. PubMed ID: 6404641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine.
    O'Connor JE; Costell M; Grisolía S
    Biochem Biophys Res Commun; 1987 Jun; 145(2):817-24. PubMed ID: 3593373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adaptation of hepatic ammonia metabolism after chronic valproate administration in epileptics treated with phenytoin.
    Marescaux C; Warter JM; Brandt C; Rumbach L; Micheletti G; Chabrier G; Imler M
    Eur Neurol; 1985; 24(3):191-5. PubMed ID: 3922765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.
    Brass EP; Beyerinck RA
    Biochem J; 1988 Mar; 250(3):819-25. PubMed ID: 3134008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver-Oriented Acute Metabolic Effects of A Low Dose of L-Carnitine under Fat-Mobilizing Conditions: Pilot Human Clinical Trial.
    Odo S; Tanabe K; Yohda M; Yamauchi M
    J Nutr Sci Vitaminol (Tokyo); 2020; 66(2):136-149. PubMed ID: 32350175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.